Dianthus Therapeutics Inc. (NASDAQ: DNTH) — Healthcare · Share Price, Chart & Market Data
About: Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $87.39 (-2.71%)
DNTHDianthus Therapeutics Inc.
Loading watchlist status…
Trade DNTH now
Dianthus Therapeutics Inc. share price
DNTH price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:47 am GMT+0
DNTH price performance
-4.928%
5D
11.254%
1M
120.237%
YTD
311.634%
1Y
DNTH price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:47 am GMT+0
DNTH details
DNTH Market Signals